M&A - Anika Therapeutics, Inc.

Form Type: 8-K

Filing Date: 2025-03-11

Corporate Action: Acquisition

Type: New

Accession Number: 000117184325001388

Filing Summary: On March 7, 2025, Anika Therapeutics, Inc. completed the sale of all outstanding equity interests of its former wholly-owned subsidiary, Parcus Medical, LLC, to Medacta Americas Manufacturing, Inc. This transaction, executed under a Membership Interest Purchase Agreement, involved the delivery of $4,500,000 in cash to Anika Therapeutics at the closing. The total consideration for the sale is subject to customary post-closing adjustments. Following the completion of the transaction, a press release was issued to announce the event.

Document Link: View Document